GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Clinical trials for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GPC3 POSITIVE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for GPC3 POSITIVE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Super CAR-T cells take on advanced liver cancer in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called Super CAR-T for people with advanced liver cancer that has not responded to standard therapies. The therapy uses a patient's own immune cells, modified to target a protein called GPC3 found on cancer cells. The main goals are to…
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New cell therapy trial targets Hard-to-Treat solid tumors
Disease control Recruiting nowThis early-phase trial is testing a new treatment called TC-G203 for people with advanced solid tumors that have a specific marker (GPC3) and have not responded to standard therapies. The main goal is to find the safest dose and check for side effects. About 30 adults will take p…
Matched conditions: GPC3 POSITIVE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 11, 2026 20:48 UTC